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Introduction. The accuracy and clinical applicability of an improved model-based system for tracking hemodynamic changes is
assessed in an animal study on septic shock. Methods. This study used cardiovascular measurements recorded during a porcine
trial studying the efficacy of large-pore hemofiltration for treating septic shock. Four Pietrain pigs were instrumented and induced
with septic shock. A subset of the measured data, representing clinically available measurements, was used to identify subject-
specific cardiovascular models. These models were then validated against the remaining measurements. Results. The system
accurately matched independent measures of left and right ventricle end diastolic volumes and maximum left and right ventricular
pressures to percentage errors less than 20% (except for the 95th percentile error in maximum right ventricular pressure) and all
𝑅
2
> 0.76. An average decrease of 42% in systemic resistance, a main cardiovascular consequence of septic shock, was observed
120 minutes after the infusion of the endotoxin, consistent with experimentally measured trends. Moreover, modelled temporal
trends in right ventricular end systolic elastance and afterload tracked changes in corresponding experimentally derived metrics.
Conclusions.These results demonstrate that thismodel-basedmethod canmonitor disease-dependent changes in preload, afterload,
and contractility in porcine study of septic shock.
1. Introduction
Cardiovascular management of the critically ill is often diffi-
cult due to the array of complex circulatory interactions that
occur within hemodynamically compromised patients. The
limited measurement set typically available in the intensive
care unit (ICU) is sometimes insufficient to give a full picture
of cardiovascular status. Hence, diagnosis and therapy are
often based on the experience, skill, and intuition of the
attending medical staff. However, difficulties in interpreting
cardiac and circulatory measurements can result in misdiag-
nosis and suboptimal treatment, whichmay lead to inefficient
use of resources, increased length of stay, and in some cases
death [1–5].
To improve hemodynamic monitoring, model-based
methods can be used to aggregate common ICU measure-
ments into an easily understandable, physiological form.
Other model-based methods have been used to estimate sur-
rogatemarkers of cardiovascular performance from clinically
available data. However, these approaches have only been
used to identify a small number of hemodynamic parameters
[6] or only describe localised behaviour [7, 8], normally to
obtain estimates of CO [9–16]. To truly understand the effects
of many common cardiovascular diseases in the ICU, one
must consider the global effects these diseases have on a
patient. Hence, a broader approach that describes the effects
of disease on parameters of cardiac function, as well as
parameters of systemic and pulmonary flows, is required.
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Patient-specific models, identified from clinical data, could
be used to help paint a clearer physiological picture of the
patient’s global cardiovascular condition and assist medical
staff with decision making [17, 18]. The goal of this research
is to show that such an in silico system can accurately identify
important disease and treatment dependent changes in the
cardiovascular system (CVS).
A previously reported model-based method [19, 20]
indicated that subject-specific disease induced hemodynamic
changes due to pulmonary embolism could be tracked
from common cardiovascular measurements. However, the
method lacked clinical applicability because invasive mea-
surements of left and right ventricular volumes waveforms
were required, which are rarely available in the ICU.Thus, an
enhanced method [21, 22] has been developed that only uses
clinically available or easily inferred cardiovascular measure-
ments, so the system can be used to monitor hemodynamics
in a normal, clinical setting.
In the ICU, some of the most prevalent and deadly
cardiovascular disorders are severe sepsis and septic shock
[1, 2] which are caused by a whole body inflammatory
response to an infection, resulting in systemic vasodilation.
To further prove the monitoring ability of this new method,
subject-specific CVS models are retrospectively identified
and validated using measurements from a porcine study
on septic shock and large-pore hemofiltration therapy [23].
Hence, in this study, the ability of subject-specific CVS
models to monitor the signs of sepsis, including a decrease
in systemic vascular resistance (𝑅sys) [24–26], an increase in
pulmonary vascular resistance (𝑅pul) [26], and an increase
right ventricle end diastolic elastances (RVEDV) [26], were
analysed.
2. Materials and Methods
This study used cardiovascular measurements recorded dur-
ing a porcine trial studying the efficacy of large-pore hemofil-
tration (LPHF) for treating septic shock [23]. Although the
efficacy of LPHF is not of particular interest to this study,
the induction of sepsis followed by LPHF provides a dynamic
and clinically realistic background on which to test this
model andmethodology.Measurements taken from four pigs
during this study provide a suitable dataset for identifying
subject-specific CVS model parameters and safely validating
themodel-outputs. In this work, subject-specific CVSmodels
were only identified frommeasurements commonly available
in the ICU. Changes in the identified parameters in these
models were analysed to track the effect of septic shock in
the pigs. No prior assumptions were made or implemented
regarding the trends in these identified parameters.Themore
invasive measurements recorded in the porcine study, which
are not widely obtainable clinically, were used to validate the
accuracy of the CVS models.
2.1. Subjects. Four pure Pietrain pigs weighing 20–30 kg were
premedicated, anesthetized, and ventilated as described in
[23, 27].The animals received a 0.5-mg/kg endotoxin infusion
(lipopolysaccharide from Escherichia coli serotype 0127:B8;
Sigma Chemical, St. Louis, MO, U.S.A) over 30 minutes
(from T0 to T30) to initiate sepsis. From T60 onwards
the pigs underwent a zero balance continuous venovenous
hemofiltration at a rate of 45mL/kg/h with a 0.7m2 large-
pore (78 A˚) membrane with a cut off of 80 kDa (Sureflux FH
70, Nipro, Osaka, Japan) and a BaxterBM 25-BM 14 hemofil-
tration device (Baxter Health Care, Munich, Germany). Each
animal acted as its own control in this study with baseline
measurements taken prior to the endotoxin infusions (T0),
representing the undiseased state of the pig. All procedures
and protocols used in the porcine experiments were reviewed
and approved by the Ethics Committee of theMedical Faculty
at the University of Liege (Belgium).
2.2. Measurements. The pulmonary trunk was accessed via
medial sternotomy, and a micromanometer-tipped catheter
(Sentron, Cordis, Miami, FL) was inserted into the main
pulmonary artery through a stab wound in the RV outflow
tract and positioned approximately 2 cm downstream of the
pulmonary valve. Aortic pressure was measured using a
micromanometer-tipped catheter inserted into the descend-
ing thoracic aorta through the right femoral artery. A 7F,
12 electrode conductance micromanometer-tipped catheter
(CD Leycom, Zoetermeer, Holland), was positioned in each
of the left and right ventricles, so that all electrodes were in
their respective cavities. Further details on the trials can be
found in [23].
These catheters provided measurements of the aortic and
pulmonary pressure waveforms (𝑃ao, 𝑃pa) and the left and
right ventricular pressure and volume waveforms (𝑃lv, 𝑉lv,
𝑃rv, and 𝑉rv). Continuous waveforms of 𝑃ao, 𝑃pa, 𝑃lv, 𝑉lv, 𝑃rv,
and 𝑉rv (sampling frequency, 𝑓𝑠 = 200Hz) were recorded
from the four catheters at 30 minutes intervals (T0, T30, T60,
. . ., T210, and T240) between initiation of anaesthesia (T0)
and 4 hours subsequent (T240). At each 30minute interval 6–
12 heartbeats of these waveforms were recorded. For each set
of waveforms one good heartbeat worth of data was selected.
From this selected heartbeat discrete convergence set points
for the parameter identification process were extracted. In
this study, 34 sets of measurements were extracted from the
raw data providing 34 sets of convergence set points from
the four pigs. Two data sets were unusable as steady-state
measurements could not be obtained.
2.3. Cardiovascular System Model. This study uses a pre-
viously validated cardiovascular system model [19, 28, 30–
32] defined by a set of equations describing cardiac and
circulatory flow.This model describes the “lumped” or global
dynamics of major regions of the CVS, ignoring smaller
localised behaviour. The lumped nature allows the model
to be relatively light computationally, requiring a smaller
number of parameters. However, it is complex enough to
capture all the clinically important hemodynamics of the
CVS.
The six chamber CVS model represents the left and
right ventricles, aorta, pulmonary artery, vena cava, and
pulmonary vein, as illustrated schematically in Figure 1. Pres-
sures and volumes in the chambers (𝑃, 𝑉) and flows between
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Figure 1: Overview of the six-chamber cardiovascular system model which relates the pressures (𝑃), volumes (𝑉), and flows (𝑄) in the
cardiovascular system using parameters of elastance (𝐸), resistance (𝑅), and inertance (𝐿); driL and driR represent cardiac muscle activation
and act as the driver functions for the CVS model.
the chambers (𝑄) are defined using parameters of resistance
to flow (𝑅), blood inertia (𝐿), and chamber elastance or stiff-
ness (𝐸). Cardiac muscle activation of the ventricles is rep-
resented using time varying elastances (driL and driR) which
act as the driver functions for the CVSmodel.The ventricular
chambers in the model are actively elastic meaning pressure
changes nonlinearly with respect to volume, to model the
effects of contraction and relaxation in these chambers. The
noncardiac chambers are passively elastic. Thus, pressure is
linearly related to volume in these chambers. Flow in and
out of the ventricles is controlled via pressure-gated heart
valves, and the parallel interaction between the ventricles
is modelled through pericardial and septal dynamics. The
combination of all these model features and parameters
provides ameans for accurately depicting ventricular, arterial,
and venous blood pressures and volumes, and the blood flow
rates through the heart valves, body, and lungs.The fullmodel
definition can be found in Hann et al. [33].
Please note that this model does not implicitly simulate
any autonomic control mechanism. However, such mech-
anisms can be indirectly simulated through alteration of
the model parameters. For example, sympathetic control of
the blood pressure could be simulated by increasing the
parameter 𝑅sys in the CVS model.
2.4. Parameter Identification Method: Pig-Specific Model. The
parameter identification method used for this study was
described by Revie et al. [21, 22]. The advantage of this
method over the previously employed technique [19, 20]
is that it only requires data from measurements typically
available in an ICU environment. Table 1 shows the small
set of measurements necessary to identify the patient-specific
parameters required for the model.
The parameter identification process was performed in
sequential stages to increase convergence stability. In this
process the inertances in the CVS model were ignored
(𝐿mt = 𝐿av = 𝐿 tc = 𝐿pv = 0), as they were found
to have negligible effect on the modelled flow. To simplify
parameter identification, the six-chamber CVS model was
divided into two submodels of the systemic and pulmonary
circulations, as shown in Figure 2.These models were decou-
pled by removing the ventricular interaction between the
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Table 1: List of identified parameters and corresponding measurements used to identify them for the simplified systemic, simplified
pulmonary, and six-chamber models. Each line on the table represents a measurement/parameter pair, where the measurement on the line is
used to directly identify the corresponding parameter. All the parameters in this table, except for the valve resistances, are uniquely identified
for each set of measurements. The valve resistances are identified for each set of measurements and then averaged for a subject.
Model Measurement Identified parameter
Name Symbol Name Symbol
Systemic
Global end diastolic volume GEDV Left ventricular elastance 𝐸es,lvf
Stroke volume SV Mitral valve resistance 𝑅mt
Mean aortic pressure MAP Systemic vascular resistance 𝑅sys
Aortic pulse pressure PPao Aortic elastance 𝐸ao
Maximum ascending aortic gradient 𝑑𝑃ao,max/𝑑𝑡 Aortic valve resistance 𝑅av
Mitral valve closure time 𝑡mt Pulmonary vein pressure 𝑃pu
Pulmonary
Global end diastolic volume GEDV Right ventricular elastance 𝐸es,rvf
Stroke volume SV Tricuspid valve resistance 𝑅tc
Mean pulmonary artery pressure MPAP Pulmonary valve resistance 𝑅pul
Pulmonary artery pulse pressure PPpa Pulmonary artery elastance 𝐸pa
Maximum ascending pulmonary artery pressure 𝑑𝑃pa,max/𝑑𝑡 Pulmonary valve resistance 𝑅pv
Tricuspid valve closure time 𝑡tc Vena cava pressure 𝑃vc
6 chamber Vena cava pressure (identified from systemic model) 𝑃vc Vena cava elastance 𝐸vc
Pulmonary vein pressure (identified from pulmonary model) 𝑃pu Pulmonary vein elastance 𝐸pu
circulations. The submodels were independently simulated
using left and right ventricular driver functions (driL and
driR) and initial estimates for parameter values. The driver
functions were identified using the method described in
[34, 35] and help define the ventricular systolic and diastolic
function in the identifiedmodels.These driver functions play
an important role in defining pig and time dependent changes
in diastolic ventricular function in the subject-specific CVS
models, as the parameters of ventricular filling (as shown
in (A.4) in the appendix) are held as constants (see Table 5)
during the identification process.
An iterative proportional gain control method [22] was
used to match the model outputs of Table 1 to the corre-
sponding measurements, identifying the desired parameter
set of Table 1. Each observable model output was used to
identify one model parameter. Parameters (𝑃) that were pro-
portionally related to their correspondingmodel output were
iteratively identified using the ratio of the true measurement
to corresponding model output:
𝑃new =
Measurement
Model Output
𝑃old. (1)
Parameters that were inversely related to their chosen model
output were identified using
𝑃new =
Model Output
Measurement
𝑃old. (2)
The parameters of the systemic submodels were identified
first, followed by the pulmonary model. Once the both
submodels were identified, they were joined together, with
coupling between the models added in the form of septum
and pericardium dynamics. The systemic and pulmonary
models were then reidentified with the knowledge of this
coupling, and the whole process was repeated until whole
CVSmodel had converged.This processwas repeated for each
measurement set for that pig (i.e., T0, T30, T60, . . ., T240).
From these identified models the valve resistances were
averaged, and the remaining parameters were reidentified
using these averaged valve resistances each measurement set
from T0 to T240. Hence, for a given pig, nine unique sets
of parameters were identified representing the hemodynamic
state of the pig at the point in the experiment. A full
description of the model identification process is provided by
Revie et al. [22] and in the appendix for the interested reader.
Figure 3 shows an example of the systemic model matching
the mean, amplitude, and maximum ascending gradient of
the aortic pressure waveform, through the identification of
𝑅sys, 𝐸ao, and 𝑅av, respectively (see (A.21), (A.22), and (A.24)
in the appendix). It should be noted that the parameter
identification method reported in [22] has been modified, so
the dead space of volumes of the ventricles is assumed to be
equal to 23mL, as reported in [36], rather than 0mL.
In this study, global end diastolic volume (GEDV) was
assumed to be equal to the sum of the left and right ventricu-
lar end diastolic volumes (LVEDV+RVEDV). Stroke volume
(SV) was calculated as the average of the amplitudes of the
left and right ventricular volume waveforms. The mitral and
tricuspid valve closure times (𝑡mt, 𝑡tc) were estimated from
the derived subject-specific left and right ventricular driver
function, (time varying elastances). These driver functions
were calculated using the method described by Hann et al.
[37] from SV and features in the aortic and pulmonary artery
pressure waveforms.
In this study, GEDV and SV were not directly measured
but instead were inferred from the experimental measure-
ments of 𝑉lv and 𝑉rv. However, clinically, GEDV and SV
can be measured using minimally invasive thermodilution
techniques [38–41]. The aortic pressure waveform can be
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Figure 2: Simplified submodels of (a) the systemic and (b)
pulmonary circulations with inertia and ventricular interaction
removed.Note that for comparison the orientation of the pulmonary
circulation has been reversed with respect to Figure 1.
estimated from radial artery pressure using one of the several
transfer functionmethods [42–47]. Pulmonary artery indices
can be determined using a pulmonary artery catheter (PAC).
Vena cava pressure,𝑃vc, can be identified from central venous
pressure which is normally measured in the ICU, removing
the need to measure 𝑡tc. Mitral valve closure time, 𝑡mt, can be
estimated from ECG data. Hence, the data set required for
model identification represents only measurements that are
already measured or inferred in a typical ICU.
2.5. Analysis. Data sets were recorded every 30 minutes from
T0 to T240 during the four trials. However, two sets of mea-
surements for Pig 1 at T30 and T90 were unusable, as the pig’s
hemodynamics were unstable at these times. Thus, 34 data
sets were available for analysis. For each data set, a subject-
specific CVS model was retrospectively identified from a
subset of available measurements. The model identification
method was run on a 2.13GHz dual core machine with 3GB
of ram. Since this research is still in the development stages it
has only been fully tested using the development-orientated
but relatively slowMATLAB software (MathWorks, Natwick,
MA, USA). Using one processor the identification method
took on average 6 minutes and 24 seconds to identify a
subject-specific model of the CVS. Preliminary tests using C
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Figure 3: Example of the features from the aortic pressurewaveform
which are matched during the model identification process.
programming language, which is better suited for real time
applications, have suggested that the identification process
time can be reduced by a factor of 20–100, to approximately
4–19 seconds per identifiedmodel, which is an acceptable run
time in a clinical environment.
During parameter identification, all the parameters listed
in Table 1 were uniquely identified for each set of measure-
ments (at T0, T30,. . ., T240), except for the valve resistances
which were averaged over the duration of the trials (T0–
T240) for each pig. The model outputs of the identified
models were compared to the remaining recorded measure-
ments to validate the accuracy of the identified models.
Averaged data is presented as mean ± one standard deviation
(1SD). A paired-sample 𝑡-test was used to check temporal
variance over T0–T60 to analyse the effect of the endo-
toxin intervention. 𝑃 < 0.05 was considered a statistically
significant result. The relationship between the modelled
and measured maximum left and right ventricular pressures
and volumes was analysed statistically using correlation and
linear regression analysis, including calculation of absolute
percentage errors, and bias and precision analysis (Bland and
Altman [48]). A percentage error less than 20% was regarded
as an acceptable result as measurement of physiological
variables often lack precision, with errors of ±10–20% not
uncommon [49–51].
3. Results
The temporal variance in the measurements of the cohort
was analysed between T0–T30, as well as T0–T60 and T30–
T60 using paired sample 𝑡-tests. Temporal variance was
analysed over T0–T60 and T30–T60 because sometimes
the symptoms of septic shock do not manifest immediately
after the endotoxin infusion at T30. Statistically significant
changes (𝑃 < 0.05) were seen in the measured systolic
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and diastolic aortic and pulmonary artery pressures and
right ventricular end diastolic volume over the first hour,
showing the expected influence of the endotoxin infusion
on the circulation. Figure 4 shows these main hemodynamic
measurements across the four animals.
3.1. Subject-Specific Model Validation. For all the subject-
specific models, the model outputs matched the measure-
ments used in the identification process (mean aortic and
pulmonary pressures, aortic and pulmonary artery pulse
pressure, and stroke volume) to percentage errors of less than
0.5%.This result is expected and indicates the convergence of
the identification process.
Validation was achieved by comparing model outputs
of left and right ventricular end diastolic volumes (LVEDV,
RVEDV) and maximum left and right ventricular pres-
sures (𝑃lv,max, 𝑃rv,max) to their correspondingmeasured value.
These measurements were not used directly in the identifica-
tion process, and thus, represent an independent validation
of the method. Bias, precision, and correlation metrics were
analysed for validation (Table 2 and Figures 5 and 6 for
LVEDV and RVEDV). All four model outputs correlated
well with the measured data (𝑅2 ≥ 0.76). Modelled left
ventricular outputs (LVEDV,𝑃lv,max) had a small negative bias
(−3.4mL, −1.6mmHg), whereas right ventricular outputs
(RVEDV, 𝑃rv,max) tended to slightly overestimate (3.8mL,
4.5mmHg) the true measurement. The precision (2 standard
deviations) of the LVEDV and RVEDV predictions was
10.2mL and 10.2mL and 12.8mmHg and 12.9mmHg for
𝑃lv,max and 𝑃rv,max. All percentage errors were within and
acceptable range (<20%), except for the 95th percentile error
in the modelled maximum right ventricular pressure.
For further validation, the temporal trends of the iden-
tified right ventricular end systolic elastance, pulmonary
afterload, and right ventricular arterial coupling (RVAC),
from the model, were compared to corresponding metrics
(𝐸es,rvf, 𝐸𝑎, and 𝐸es,rvf/𝐸𝑎). These metrics were determined
experimentally in [23] using right ventricular pressure-
volume analysis, for 𝐸es,rvf, and a windkessel model, for 𝐸𝑎.
The afterload on the right ventricle in the model is the sum
of the resistance of the pulmonary valve and pulmonary
vasculature divided by the period of one heartbeat (𝐸
𝑎,model =
[𝑅pv + 𝑅pul]/𝑇). From Figure 7 it is seen that the subject-
specific models in most cases track the experimental trends
in 𝐸es,rvf and 𝐸𝑎. Weaker relationships are seen between the
modelled and experimentally RVAC metrics (𝐸es,rvf /𝐸𝑎).
However, the model did capture all the averaged temporal
trends for the cohort with 𝑅2 = 0.62, 94, and 0.71 for
𝐸es,rvf,𝐸𝑎, and𝐸es,rvf /𝐸𝑎. Note that experimental datawas not
available for Pig 1 at T0, T30, and T90, and Pig 2 at T150, due
to difficulties performing the vena cava occlusionmanoeuvre.
3.2. Septic Shock Trends. Averaged model metrics were used
to test whether the subject-specificCVSmodels could capture
the general trends of septic shock across the cohort of pigs.
These metrics include ventricular preload, afterload, and
contractility, three of the main determinants of cardiac and
circulatory function. The averaged temporal trends for the
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Figure 4: Evolution of the averaged hemodynamic measurements
recorded during the trials. ∗indicates𝑃 < 0.05 for expected temporal
changes over T0–T30, T0–T60, or T30–T60 due to the induction of
septic shock.Thedata is presented asmean±one standard deviation.
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Table 2: The median and range of the measured left and right end diastolic volumes (LVEDV, RVEDV) and maximum left and right
ventricular pressures (𝑃lv,max, 𝑃rv,max). Bias and precision metrics (2SD), median percentage errors with 5th and 95th percentile bounds,
and correlation coefficients of the modelled LVEDV, RVEDV, 𝑃lv,max, and 𝑃rv,max.
Median (range) Bias ± 2SD % Error (5th–95th percentile) 𝑅2
LVEDV 97.7mL (55.0–141.2) −3.4 ± 10.2mL 3.5% (0.5–10.9) 0.98
RVEDV 93.3mL (44.8–138.2) 3.8 ± 10.2mL 4.9% (0.4–16.3) 0.96
𝑃lv,max 86.1mmHg (63.2–121.8) −1.6 ± 12.8mmHg 3.8% (0.4–16.4) 0.96
𝑃rv,max 38.7mmHg (18.0–60.7) 4.5 ± 12.9mmHg 14.8% (2.6–29.9) 0.76
40 60 80 100 120 140 160
40
60
80
100
120
140
160
LVEDV measured (mL)
LV
ED
V
 m
od
el
le
d 
(m
L)
𝑌 = 0.87𝑋 + 8.72; 𝑅2 = 0.98
𝑁 = 34
(a)
40 60 80 100 120 140 160
0
5
10
15
20
LVEDV mean (mL)
LV
ED
V
 b
ia
s (
m
L)
−20
−15
−10
−5
(b)
Figure 5: Regression (a) and Bland-Altman analysis showing 2
standard deviation limits (b) of the modelled and measured left
ventricular end diastolic volume (LVEDV).
metrics used in this analysis are shown in Figure 8. Please
note that the spike in some of these metrics at T30 due to
initial reaction of the pigs to endotoxin insult is not discussed
in the following sections. The analysis of preload, afterload,
and contractility, as presented in the following, only focuses
on overall trends seen in these parameters over the four-hour
duration of the trials.
3.3. Preload. In the model, preload on the ventricles is
represented by end diastolic volumes in the left and right
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Figure 6: Regression (a) and Bland-Altman analysis showing 2
standard deviation limits (b) of the modelled and measured right
ventricular end diastolic volume (RVEDV).
ventricles (LVEDV, RVEDV). The average modelled LVEDV
and RVEDV are shown in Figure 8. These results show the
subject-specific models identified an increase in RVEDV
during the study indicating the onset of right ventricle
distension. In contrast, an initial decrease in LVEDV was
observed, suggesting a decrease in venous return to the left
heart immediately after the endotoxin infusion. However,
LVEDV does start to increase during the second half of the
trial indicating the activation of left ventricle compensatory
mechanismwhich combats the effects of low venous return to
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right ventricular arterial coupling (𝐸es,rvf/𝐸𝑎), represented by the black symbols, against experimentally derivedmetrics from [23], represented
by the white symbols.
the heart. Both these observations are known consequences
of septic shock [25, 26].
3.4. Afterload. Another main hemodynamic consequence of
septic shock is sudden decrease in left ventricle afterload
due to a systemic inflammation [24–26]. In the model, the
parameter systemic vascular resistance (𝑅sys) represents the
main component of the afterload on the left ventricle. The
average trends for𝑅sys, alongwith its pulmonary counterpart,
pulmonary vascular resistance (𝑅pul), can be seen in Figure 8.
These identified trends show a significant decrease in 𝑅sys
after T60, symptomatic of sepsis. Moreover, a steady increase
in 𝑅pul after T60 was observed by the subject-specific CVS
models, indicating an increase in right ventricle afterload due
to the effects of the endotoxin. Again, both these findings are
indicative of septic shock [24–26].
3.5. Contractility. In the subject-specific CVS models con-
tractility is represented by parameters of left and right
ventricular end systolic elastance (𝐸es,lvf, 𝐸es,rvf), as shown
in Figure 8. In septic shock a decrease in these parameters
is expected due to myocardial depression [25, 26, 52, 53].
However, contrary to this expected trend, the averaged
values for 𝐸es,lvf and 𝐸es,rvf stayed relatively constant over
the trial. This unexpected outcome may be the consequence
of the hemofiltration therapy, which has been shown to
improve cardiac function during endotoxic shock in several
experimental studies [23, 54, 55]. On the other hand, these
results could be due to autonomous reflex responses, such as
baroreflex control, attempting to maintain blood pressure by
increasing contractility [56]. As a result, such mechanisms
could be counteracting the effects of decreased myocardial
state in the pigs. Since autonomous control mechanisms are
not directly simulated in the CVS model it is impossible to
fully distinguish if changes in themodel parameters are due to
the effects of thesemechanisms or a result of the administered
therapy.
3.6. Subject-Specific Response. Although the averaged results,
seen previously, show that the model is capable of identifying
the hemodynamic trends of the induced disease, it is also
important to know how each subject responds to the disorder
and corresponding treatment. Hence, it is essential to analyse
the individual time varying trends for each pig, not just the
averaged trends of the disease. Figure 8 illustrates the subject-
specific response of 𝑅sys to the endotoxic shock and LPHF
therapy. On average, systemic resistance drops by 20.3%
across the four pigs over the duration of the trials. However,
when analysing the individual response of each of the pigs,
it is seen that the 𝑅sys returns to baseline for Pig 2, and
a substantial improvement is observed in Pig 1 after LPHF
treatment (T60 onwards). Whereas, there are large drops in
𝑅sys with no apparent improvement with treatment in Pigs
3 and 4, indicating the difference response to septic shock
between the pigs.
4. Discussion
4.1.Modelling Errors. For validation themodelwas compared
to independent measurements that were not used in the
identification process, as well as pulmonary hemodynamic
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Figure 8: Modelled subject-specific indices of preload (end diastolic volume), afterload (vascular resistance), and contractility (end systolic
elastance).The grey symbols represent the left ventricle or systemicmetrics.The black symbols represent right ventricle or pulmonarymetrics.
indices calculated using an independentmethod [23]. Almost
all ventricular volumes (LVEDVandRVEDV) andmaximum
pressures (𝑃lv,max and 𝑃rv,max) were identified to an error
of less than 20% (except the 95th percentile error in the
maximum right ventricular pressure), which is acceptable for
this type of physiological monitoring. Furthermore, the time
varying trends in these four measurements were identified to
a high degree of accuracy, with calculated 𝑅2 > 0.90, except
for the maximum right ventricular pressure where 𝑅2 =
0.76, which is still a very good result. These results suggest
that subject-specific models of the CVS could be used to
accurately monitor disease-dependent changes in ventricular
preload in an intensive care environment.
In most cases, the temporal trends of right ventricular
end systolic elastance and pulmonary afterload from the
subject-specific CVS models correlated well to experimen-
tally derived measurements of 𝐸es,rvf and 𝐸𝑎 from [23]. The
modelled results tended to underestimate𝐸es,rvf.The primary
reason for this bias is because of the assumption in the
model identification process that the dead space volume of
the right ventricle (𝑉
𝑑,rvf) is constant and equal to 23mL,
as reported in [36]. In reality, 𝑉
𝑑,rvf most likely changes as
the contractile state of the pigs changes during the trials,
but due to the lack of available measurements it cannot be
identified. Hence, in the model the changes in contractile
state are solely represented by 𝐸es,rvf. Poorer correlations
were also noticed for RVAC. The reason for these poor
relationships is most likely due to accumulation of errors in
calculating this compound metric (𝐸es,rvf/𝐸𝑎). These include
the addition of error due to measurement noise in the
experimental metrics and the addition of modelling errors
in the identified parameters. However, a strong temporal
relationship for RVAC could be seen of 𝑅2 = 0.71 when
the effects of measurement noise and modelling error were
averaged over the cohort (as seen in Figure 7).
Noticeably, there were larger errors in themodelled𝐸es,rvf
and 𝐸
𝑎
for Pig 4, as seen in Figure 7. This pig had a substan-
tially higher heart rate than the other pigs, on average around
150 beats per minute compared to 122, 49, and 113 beats per
minute for Pigs 1, 2, and 3. As a result, Pig 4 had a very high
cardiac output up to seven times higher than the other pigs.
In this extreme case, the CVS model was unable to capture
the high flow dynamics of Pig 4. However, work is currently
underway to improve the model for these types of cases.
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Table 3: Identified CVS model parameters and the measurements (convergence set points) used to identify them.
Identified parameter Measurement used to identify parameter
Symbol Description Symbol Description
𝐸es,lvf Left ventricle end systolic elastance GEDV Global end diastolic volume
𝐸ao Aortic elastance PPao Amplitude of aortic pressure
𝐸vc Vena cava elastance 𝑃vc Modelled Vena cava pressure
𝐸es,rvf Right ventricle end systolic elastance GEDV Global end diastolic volume
𝐸pa Pulmonary artery elastance PPao Amplitude of pulmonary artery pressure
𝐸pu Pulmonary vein elastance 𝑃vc Modelled vena cava pressure
𝑅mt Mitral valve resistance SV Stroke volume
𝑅av Aortic valve resistance 𝑑𝑃ao,max/𝑑𝑡 Maximum ascending aortic pressure gradient
𝑅sys Systemic vascular resistance 𝑃ao,mean Mean aortic pressure
𝑅tc Tricuspid resistance SV Stroke volume
𝑅pv Pulmonary valve resistance 𝑑𝑃ao,max/𝑑𝑡 Maximum ascending pulmonary artery pressure gradient
𝑅pul Pulmonary vascular resistance 𝑃po,mean Mean pulmonary artery pressure
𝑃vc Vena cava pressure 𝑡tc, SV Tricuspid valve closure time and stroke volume
𝑃pu Pulmonary vein pressure 𝑡mt, SV Mitral valve closure time and stroke volume
A primary cause of some of the larger errors and differ-
ence in polarity of the mean errors between the left and right
ventricle measurements, as seen in Table 2, is the inherent
difficulty of measuring and calculating the right ventricular
volume experimentally with a conductance catheter. Due to
the complex shape of the right ventricle, the volumemeasure-
ments were underestimated, especially for Pigs 3 and 4, where
the left ventricular SV appeared to be more than double the
right ventricular SV. The CVS is essentially a closed system
and the ventricles pump in series. Hence, it is unsustainable
for their SV of the ventricles to be a largely different for more
than a couple of heartbeats, during a transient period, or else
there would be a large buildup of volume somewhere in the
circulation.However, themeasurements were takenwhen the
pigs were hemodynamically stable and should reflect steady
state conditions. Hence, it is obvious that the measured right
ventricular volume is underestimating the true volume in the
right ventricle.
To overcome these measurement problems, the average
value of themeasured left and right ventricular stoke volumes
was used in the model identification process for both ven-
tricles. Thus, once converged, the identified models generally
underestimated the measured left ventricular stoke volume
and overestimated the measured right ventricular stroke vol-
ume. This issue caused the LVEDV and, consequentially, the
left ventricular pressure in the model to be underestimated
relatives to the measurements taken in the experiment, with
the opposite occurring in the right ventricle. However, more
importantly, these errors were generally systematic, so the
trends associated with these measurements are still clearly
identified and accurate.
4.2. Detecting Septic Shock. The subject-specific models of
the CVS captured the main hemodynamic trends of septic
shock. A drop in systemic vascular resistance and an increase
in pulmonary vascular resistance were identified. As a result,
an increase in RVEDV was also seen in the subject-specific
CVS models. These changes are well-known consequences
of the disease [24–26]. Hence, these results indicate that the
identified models are able to accurately capture the expected
trends of septic shock in the pigs.
4.3. Subject-Specific Modelling. The results show that per-
sonalised CVS models can be used to accurately match
and predict important hemodynamic markers of afterload
(𝑅sys, 𝑅pul), preload (LVEDV, RVEDV), and contractility
(𝐸es,lvf, 𝐸es,rvf). Clinically, the contractile state and preload
on the ventricles can be extremely difficult to continuously
measure using traditional techniques. Generally, LVEDV
and RVEDV can only be estimated intermittently using
echocardiography, and there exists no widely accepted clin-
ical measure of contractility. The model-based approach,
used in this paper, provides a way to continuously estimate
preload and contractility. These model-based metrics could
be used to help guide therapy such as using fluids to increase
LVEDV and the administering inotropes to control 𝐸es,lvf
and 𝐸es,rvf. The accurate and continuous monitoring of
preload is especially important in septic shock, as it has
been shown that early goal-directed fluid resuscitation can
increase patient outcomes [57]. Hence, metrics derived from
identified subject-specific CVS models could help provide
more meaningful targets for similar goal-directed therapies.
The subject-specific models were also able to track the
main hemodynamic changes resulting from induced septic
shock. These results show that the new model identifica-
tion method utilised is capable of accurately identifying
markers of cardiovascular health, like the previous integral-
based method [19, 20] but requires a much smaller, more
clinically available set of measurements including features
(mean, amplitude, and maximum gradient) of the aortic
and pulmonary artery pressures, SV, GEDV, and the mitral
and tricuspid valve closure times. This measurement set
is significantly smaller than the one used in the integral-
based approach, in the sense that only discretemeasurements
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are used instead of full pressure and volume waveforms.
However, this new measurement set represents the most
important features of these waveforms. For example, instead
of fitting the integral of the aortic pressure the new method
fits the mean, amplitude, and maximum gradient of aortic
pressure in the CVS models, which are of more clinical
importance. Hence, although less data is used to identify
subject-specificCVSmodels, themodels are actuallymatched
to larger number of features within this data. Therefore,
the smaller measurement set does not decrease the number
of parameters that can be identified in these models, and
its use increases the clinical applicability of the parameter
identification method.
From the subject-specific CVS models, identified from
this minimal set of measurements, the contrasting reaction
of the pigs in response to the induced disease could be seen.
Initially,𝑅sys decreased in all the pigs, but in later stages of the
trials 𝑅sys increased in Pigs 1 and 2, increasing aortic blood
pressure in these pigs. These results tentatively suggest that
the LPHF was responsible for increasing 𝑅sys through the
removal inflammatory inducing molecules from the blood
stream. However, this treatment appeared to have little effect
on Pigs 3 and 4. Larger trials would be required before
a more substantiated conclusion on this therapy could be
made, which was not the goal of this research. However, it is
clear that the identified CVS models were able to accurately
segregate those subjects who did (and did not) respond
positively to the endotoxin insult, due either to autonomous
compensatory reflexes or because of the effects of this therapy.
The parameter identification method used in this study
is a significant improvement on previous work [19, 20]
especially with respect to clinical feasibility. Although the
measurements in this study were only taken intermittently
every 30 minutes, the system has the potential to provide
continuous real-time information to medical staff. Accurate
model identification can be achieved using low fidelity
pressuremeasurements, as only themain features of the aortic
and pulmonary artery pressure are required such as themean,
amplitude, and maximum gradient. In practice, the aortic
pressure could be inferred from the radial artery pressure
using several possible methods [42, 44, 46, 47]. The method
could also be implemented in the ICU at little extra cost, as it
only uses measurements already taken in the ICU. Thus, the
approach could be applied without adding further invasive
burden to the patient. In addition, the system can be easily
automated, so that a full picture of a patient’s hemodynamic
state is available to clinicians with little extra effort required
from medical staff.
4.4. Limitations. The number of parameters that can be
identified in the CVS model is limited by the paucity of
available measurements in the ICU, and thus, the amount
of measurements that were used to identify pig-specific CVS
models in this research. In this study only 14 out of a possible
37 parameters of the CVS model were identified. However,
these 14 parameters control all the important dynamics in the
model, including the contractility of the ventricles, vascular
stiffness, and resistance to flow through parts of the CVS. In
a clinical setting, these parameters can be controlled using
common therapies including the administration of inotropes,
vasoactive drugs, and/or fluid resuscitation. The other 23
parameters primarily have lesser effects, such as the inertia
of blood through the heart valves, or are relatively constant
over the population and are thus modelled as such, enabling
accurate relative trend identification.The good validation and
diagnostic results obtained in this study support the choice of
model parameters to be identified.
A further limitation is the use of systemic and vascular
resistance as the primary metric for ventricular afterload,
although this approach is widely used [58–61]. A more
complicated description of right ventricular afterload was
utilised for validation, as shown earlier in Figure 7, so that
themagnitude and units of themetric aligned with the exper-
imentally derived value. However, clinically, systemic and
pulmonary vascular resistances are still the most commonly
used definitions of afterload [58]. Hence, the systemic and
pulmonary vascular resistances were chosen for examination
of afterload in this study.
5. Conclusion
This study presented a method for identifying pig-specific
CVS models of endotoxic shock. These models were able to
identify expected disease-dependent changes in ventricular
preload, afterload, and contractility in the pigs, using typically
available ICU measurements. These indices of cardiac func-
tion can be difficult, impossible, or impractical to monitor
clinically but are extremely useful to know when guiding
cardiovascular therapy. Hence, this model-based approach
could potentially be used to help monitor these determinants
of cardiac function and assist clinicians with diagnosis and
treatment-based decisions.
Appendix
The CVS model is defined by (A.1)–(A.16). A full list of the
model parameters, constants, and outputs is listed in Tables
3, 4, 5, and 6. Equation (A.1) describe the flow, 𝑄, through
the heart valves. These first-order differential equations state
that the pressure (𝑃) difference across a valve is proportional
to the sum of the resistive (𝑄𝑅) and inertial effects (𝐿?̇?) on
the flow as follows:
𝐿av?̇?av = 𝑃lv − 𝑃ao − 𝑄av𝑅av,
𝐿mt?̇?mt = 𝑃pu − 𝑃lv − 𝑄mt𝑅mt,
𝐿pv?̇?pv = 𝑃rv − 𝑃pa − 𝑄pv𝑅pv,
𝐿 tc?̇?tc = 𝑃vc − 𝑃rv − 𝑄tc𝑅tc.
(A.1)
Nonvalvular flow is represented using Ohm’s law (A.2).
Hence, the flow through the vasculature is proportional to
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Table 4: Identified cardiac driver functions (normalised time varying elastances) and the measurements used to calculate them.
Identified cardiac activation Measurement used to identify waveform
Symbol Description Symbol Description
driL(𝑡) Left ventricle normalised time varying elastance 𝑃ao, GEDV Aortic pressure waveform and global end diastolic volume
driR(𝑡) Right ventricle normalised time varying elastance 𝑃pa, GEDV Pulmonary artery pressure and global end diastolic volume
Table 5: CVS model constants (from [28, 29]).
Symbol Description Value
𝑃0,lvf Parameter of left ventricle EDPVR 0
𝜆lvf Parameter of left ventricle EDPVR 0.033
𝑉
𝑑,lvf Parameter of left ventricle ESPVR 23
𝑃0,rvf Parameter of right ventricle EDPVR 0
𝜆rvf Parameter of right ventricle EDPVR 0.023
𝑉
𝑑,rvf Parameter of right ventricle ESPVR 23
𝑉
𝑑,spt Parameter of septal ESPVR 2
𝑉0,spt Parameter of septal EDPVR 2
𝜆spt Parameter of septal EDPVR 0.435
𝑃0,spt Parameter of septal EDPVR 1.1101
𝐸es,spt Septum elastance 48.7540
𝑃0,pcd Parameter of pericardium 0.5003
𝑉0,pcd Parameter of pericardium 200
𝜆pcd Parameter of pericardium 0.03
𝑃th Intrathoracic pressure 0
𝑉
𝑑,ao Aortic unstressed volume 0
𝑉
𝑑,vc Vena cava unstressed volume 0
𝑉
𝑑,pa Pulmonary artery unstressed volume 0
𝑉
𝑑,pu Pulmonary vein unstressed volume 0
𝐿mt Mitral valve inertance 0
𝐿av Aortic valve inertance 0
𝐿 tc Tricuspid valve inertance 0
𝐿pv Pulmonary valve inertance 0
the pressure difference across the section divided by the
resistance to flow as follows:
𝑄sys =
𝑃ao − 𝑃vc
𝑅sys
,
𝑄pul =
𝑃pa − 𝑃pu
𝑅pul
.
(A.2)
Pressure in the noncardiac chambers is proportional to
the elastance (𝐸) and stressed blood volume within the
chamber. In these chambers the elastances are assumed to
be constant over a heartbeat. The stressed blood volume in
(A.3) is represented as the total blood volume (𝑉) minus
the unstressed volume (𝑉
𝑑
). Chambers within the thoracic
cavity, as shown in Figure 1, are additionally influenced by the
Table 6: Full list of the CVS model outputs. Check marks indicate
outputs that are also experimentally measured.
Symbol Description Measured
𝑉lv Left ventricle volume √
𝑉ao Aorta volume
𝑉vc Vena cava volume
𝑉rv Right ventricle volume √
𝑉pa Pulmonary artery volume
𝑉pu Pulmonary vein volume
𝑃lv Left ventricle pressure √
𝑃ao Aorta pressure √
𝑃vc Vena cava pressure
𝑃rv Right ventricle pressure √
𝑃pa Pulmonary artery pressure √
𝑃pu Pulmonary vein pressure
𝑄mt Mitral valve flow rate
𝑄av Aortic valve flow rate
𝑄sys Systemic flow rate
𝑄tc Tricuspid valve flow rate
𝑄pv Pulmonary valve flow rate
𝑄pul Pulmonary flow rate
𝑉spt Septum volume
𝑃pcd Pericardium pressure
intrathoracic pressure (𝑃th) in the thoracic cavity as follows:
𝑃pu = 𝐸pu (𝑉pu − 𝑉𝑑,pu) + 𝑃th,
𝑃pa = 𝐸pa (𝑉pa − 𝑉𝑑,pa) + 𝑃th,
𝑃vc = 𝐸vc (𝑉vc − 𝑉𝑑,vc) + 𝑃th,
𝑃ao = 𝐸ao (𝑉ao − 𝑉𝑑,ao) .
(A.3)
The free wall pressure of the left and right ventricles (𝑃lvf,𝑃rvf)
is calculated using (A.4). These equations ignore the effects
of the intraventricular septum and pericardium which are
taken into account later with (A.11)–(A.19), hence, the name
free wall pressures. Myocardial activation of the left and right
ventricles are represented using normalised time varying
elastance curves (driL and driR) which vary in time between
0 and 1. The first term in both of these equations represent
the percentage of the pressure generation in the ventricle due
to dynamic contraction of the heart muscles. At maximum
contraction, driL and driR equals 1, and the pressure volume
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Table 7: Initial systemic model parameter inputs.
Parameter 𝑃pu 𝑅mt 𝐸es,lvf 𝑅av 𝐸ao 𝑅sys 𝑃vc
Initial value 5 0.05 2 0.04 2.5 2.5 5
Table 8: Initial pulmonary model parameter inputs.
Parameter 𝑃vc 𝑅tc 𝐸es,rvf 𝑅pv 𝐸pa 𝑅pul 𝑃pu
Initial value 5 0.04 0.8 0.03 2.1 0.4 5
relationship in the ventricles is represented by their end
systolic pressure volume relationship (ESPVR). The second
term represents the percentage of pressure generation due to
the passive elastic recoil of the ventricular chambers. When
driL and driR equal 0, the pressures in these chambers are
bound by their end diastolic pressure volume relationship
(EDPVR). In between end systole and end diastole the
nonlinear ventricular pressure volume relationship is defined
as a weighted sum of the ESPVR and EDPVR. In other words,
(A.4) represents the percentage of dynamic and passive
pressure generation that is occurring in the ventricles at any
point in time, as defined by
𝑃lvf = driL ⋅ 𝐸es,lvf ⋅ (𝑉lvf − 𝑉𝑑,lvf) + (1 − driL)
⋅ 𝑃
0,lvf ⋅ (𝑒
𝜆lvf(𝑉lvf −𝑉0,lvf) − 1) ,
𝑃rvf = driR ⋅ 𝐸es,rvf ⋅ (𝑉rvf − 𝑉𝑑,rvf) + (1 − driR)
⋅ 𝑃
0,rvf ⋅ (𝑒
𝜆rvf(𝑉rvf − 𝑉0,rvf) − 1) .
(A.4)
The volume of blood in the noncardiac chambers varies
at a rate proportional to the flow exiting and entering
those chambers, as described by (A.5)–(A.8). Furthermore,
(A.9) and (A.10), representing the volume in the left and
right ventricles, take into consideration the nonlinear effects
of valvular flow by using Heaviside functions. The use of
Heaviside functions in these equations ensures that there is
no backwards flow through the heart valves as follows:
?̇?pv = 𝑄pul − 𝑄mt, (A.5)
?̇?pa = 𝑄pv − 𝑄pul, (A.6)
?̇?vc = 𝑄sys − 𝑄tc, (A.7)
?̇?ao = 𝑄av − 𝑄sys, (A.8)
?̇?rv = Heaviside (𝑄tc) 𝑄tc −Heaviside (𝑄pv)𝑄pv, (A.9)
?̇?lv = Heaviside (𝑄mt) 𝑄mt −Heaviside (𝑄av) 𝑄av. (A.10)
Finally, ventricular interaction is modelled through con-
sidering the action of the intraventricular septum and the
pericardium on cardiac dynamics. Equation (A.11) represents
all the pressures acting on the intraventricular septum, where
the muscle activation of the septum (driS) is assumed to
be equal to the average of the left and right ventricular
normalised time varying elastance curves (driL, driR). From
(A.11) the blood volume displaced by the septum, 𝑉spt, can
be evaluated and used to calculate the real left and right
ventricular volumes (𝑉lv, 𝑉rv), as shown by (A.13) and (A.14)
as follows:
driS ⋅ 𝐸es,spt ⋅ (𝑉spt − 𝑉𝑑,spt) + (1 − driS)
⋅ 𝑃
0,spt ⋅ (𝑒
𝜆spt(𝑉spt − 𝑉0,spt) − 1)
= driL ⋅ 𝐸es,lvf ⋅ (𝑉lv − 𝑉spt) + (1 − driL)
⋅ 𝑃
0,lvf ⋅ (𝑒
𝜆lvf(𝑉lv − 𝑉spt) − 1) − driR ⋅ 𝐸es,rvf
⋅ (𝑉rv + 𝑉spt) − (1 − driR) ⋅ 𝑃0,rvf
⋅ (𝑒
𝜆rvf(𝑉rv + 𝑉spt) − 1) ,
(A.11)
driS = driL + driR
2
, (A.12)
𝑉lvf = 𝑉lv − 𝑉spt, (A.13)
𝑉rvf = 𝑉rv + 𝑉spt. (A.14)
The pressure generated by the pericardium (𝑃pcd), which
encases the heart, is proportional to the sum of the left
and right ventricular volumes (𝑉pcd) as described by (A.15)
and (A.16). The total external pressure acting on the cardiac
chamber (𝑃peri), as seen in (A.17)–(A.19), is therefore the sum
of the pericardium and intrathoracic pressure, as the heart
is located in the thoracic cavity. Please see [28, 30–32], for a
more detailed description of the derivation of the CVSmodel
equations. One has
𝑃pcd = 𝑃0,pcd (𝑒
𝜆pcd(𝑉pcd − 𝑉0,pcd) − 1) , (A.15)
𝑉pcd = 𝑉lv + 𝑉rv, (A.16)
𝑃peri = 𝑃pcd + 𝑃th, (A.17)
𝑃lv = 𝑃lvf + 𝑃peri, (A.18)
𝑃rv = 𝑃rvf + 𝑃peri. (A.19)
Equations (A.17)–(A.34) make up the identification process.
Table 3 lists all the parameters identified in the identification
process and convergence set points used to identify them.
Table 4 lists the driver functions, also known as time varying
elastances used to simulate the effect of cardiac contraction
in the left and right ventricles in the CVSmodel, and Tables 7
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and 8 list the initial parameters estimates used to commence
the parameter identification process.
Initially, the driver functions for the left and right ventri-
cles are estimated using GEDV and features from the aortic
pressure waveform (for driL) and pulmonary artery pressure
waveform (for driR) using the method described in [34, 35].
The systemic model is identified first. The model is initially
simulated using the parameters values given in Table 7. A
method is then used to iteratively simulate and improve the
estimates of 𝑅mt, 𝐸ao, and 𝑅sys in the systemic submodel
by matching the modelled SV, PPao and 𝑃ao,mean to their
measured value as follows:
𝑅mt,new = (
SVlv,approx
SVtrue
)𝑅mt,old, (A.20)
where SVlv,approx = max(𝑉lv) −min(𝑉lv),
𝐸ao,new = (
PPao,true
PPao,approx
)𝐸ao,old, (A.21)
where PPao = max(𝑃ao) −min(𝑃ao),
𝑅sys,new = (
𝑃ao,mean,true
𝑃ao,mean,approx
)𝑅sys,old, (A.22)
where 𝑃ao,mean = (max(𝑃ao) +min(𝑃ao))/2.
Once themodelled SV, PPao, and𝑃ao,mean have converged,
new estimates of 𝑃pu and 𝑅av are identified. 𝑅mt, 𝐸ao, and
𝑅sys are then reidentified with the new estimates of 𝑃pu and
𝑅av, and the whole process is repeated until 𝑃pu does not
change between iterations, and 𝑑𝑃ao,max/𝑑𝑡 converges to its
measured value. In this process, 𝑃pu and 𝑅av are identified
independently of 𝑅mt, 𝐸ao, and 𝑅sys, as they interact and are
dependent on the correct convergence of these parameters as
follows:
𝑃pu = 𝑃lv (𝑡mt) , (A.23)
𝑅av,new =
(𝑑𝑃ao,max,approx/𝑑𝑡)
(𝑑𝑃ao,max,true/𝑑𝑡) 𝑅av,old
. (A.24)
During this process 𝐸es,lvf is left as its constant value to be
identified later in the identification process.
The same approach is used to identify the pulmonary
sub-model, as the pulmonary model essentially mirrors the
systemic model. 𝑅tc, 𝐸pa, and 𝑅pul are identified first. Then
𝑃vc and 𝑅pv are updated, these values are used to reidentify
𝑅tc, 𝐸pa, and 𝑅pul, and the process is repeated until SV, PP,
𝑃ao,mean, 𝑃vc, and 𝑑𝑃ao,max/𝑑𝑡 have converged. During this
process𝐸es,rvf is held as its original value to be identified later.
Consider
𝑅tc,new = (
SVrv,approx
SVtrue
)𝑅tc,old, (A.25)
where SVrv,approx = max(𝑉rv) −min(𝑉rv),
𝐸pa,new = (
PPpa,true
PPpa,approx
)𝐸pa,old, (A.26)
where PPpa = max(𝑃pa) −min(𝑃pa),
𝑅pul,new = (
𝑃pa,mean,true
𝑃pa,mean,approx
)𝑅pul,old. (A.27)
where 𝑃pa,mean = (max(𝑃pa) +min(𝑃pa))/2
𝑃vc = 𝑃rv (𝑡tc) (A.28)
𝑅pv,new =
(𝑑𝑃pa,max,approx/𝑑𝑡)
(𝑑𝑃pa,max,true/𝑑𝑡) 𝑅pv,old
(A.29)
Once, the systemic and pulmonary submodelss have con-
verged,𝐸es,lvf and𝐸es,rvf are updated. First, the sum of the end
systolic elastances (𝐸es,sum) is updated by matching GEDV as
follows:
𝐸es,sum,new =
GEDVapprox
GEDVtrue
𝐸es,sum,old, (A.30)
where GEDVapprox = max(Vlv) +max(Vrv ).
Then a relationship, derived from the afterloads on the
left and right ventricles, is used to calculate the relative
contribution of 𝐸es,lvf from this sum. The derivation of this
relationship is shown in [22] as follows:
𝐶
𝐸
=
𝑃ao,mean,true − 𝑃vc
𝑃ao,mean,true + 𝑃pa,mean,true
≈
𝐸es,lvf
𝐸es,lvf + 𝐸es,rvf
= const,
(A.31)
𝐸es,lvf = 𝐶𝐸,mean𝐸es,sum (A.32)
Finally, 𝐸es,rvf can also be found using
𝐸es,rvf = 𝐸es,sum,new − 𝐸es,lvf. (A.33)
During this step in the identification process, ventricular
interaction, in the form of septal and pericardial dynamics
(𝑉spt and 𝑃pcd) are calculated and added to the systemic
and pulmonary submodelss to couple the systems. Once
𝐸es,lvf and 𝐸es,rvf have been updated, and 𝑉spt and 𝑃pcd have
been calculated, the systemic and pulmonary models are
reidentified using the new values for these parameters and
interactions. This overall process, for identifying 𝐸es,lvf and
𝐸es,rvf, is repeated until GEDVconverges, thus completing the
identification of the systemic and pulmonary models.
The systemic and pulmonary models are then identified
for the remaining measurement sets, T0–T240 for that pig.
The valve resistance are averaged across these models with
these averaged valve resistance used to reidentify the systemic
and pulmonary models. Hence, (A.20), (A.24), (A.25), and
(A.29) are no longer required, and (A.23) and (A.28) are
replaced by (A.34) and (A.35) for identifying 𝑃pa and 𝑃vc as
follows:
𝑃pu,new =
SVlv,approx
SVtrue
𝑃pu,old, (A.34)
𝑃vc,new =
SVrv,approx
SVtrue
𝑃vc,new. (A.35)
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Step 1: Input set of measured data and extract desired convergence set points.
Step 2: Approximate left and right ventricle driver functions.
Step 3: Estimate an initial set of input parameters for systemic and pulmonary models as shown in  Tables 7 and 8.
Step 4: Identify systemic model.
Substep 4.1: Simulate systemic model.
Substep 4.2: Identify 𝑅mt , 𝐸ao, and 𝑅sys with (A28)–(A30).
Substep 4.3: Resimulate the systemic model with new parameters.
Substep 4.4: If SVlv,approx, PPao,approx, and 𝑃ao,mean,approx have converged within a tolerance of 0.5%
go to Substep 4.5; otherwise go back to Substep 4.2.
Substep 4.5: Identify𝑃pu and 𝑅av with (A31) and (A32).
Substep 4.6: If 𝑃pu and (𝑑𝑃ao,mean,approx/𝑑𝑡) have converged within a tolerance of 0.5% go to Step 5; otherwise
go back to Substep 4.2.
Step 5: Identify pulmonary model.
Substep 5.1: Simulate pulmonary model.
Substep 5.2: Identify𝑅tc , 𝐸pa , and 𝑅pul for the (A33)–(A35).
Substep 5.3: Resimulate the pulmonary model with new parameters.
Substep 5.4: If SVrv,approx, PPpa,approx, and 𝑃pa,mean,approx have converged within a tolerance of 0.5%
go to Substep 5.5; otherwise go back to Substep 5.2.
Substep 5.5: Identify𝑃vc and 𝑅pv with (A36) and (A37).
Substep 5.6: If 𝑃vc and (𝑑𝑃pa,mean,approx/𝑑𝑡) have converged within a tolerance of 0.5% go to Step 6; otherwise
go back to Substep 5.2.
Step 6: Identify 𝐸es,lvf and 𝐸es,rvf with (A38), (A40), and (A41), and calculate𝑉spt and 𝑃pcd
with (A19) and (A23). If GEDVapprox, 𝑉spt , and 𝑃pcd have converged within a tolerance of 0.5%
go to Step 6; otherwise go back to Step 4.
Step 7: Repeat Steps 1 to 6 with remaining sets of the measured data for the given pig and store and average
the identified valve resistance.
Step 8: Repeat Steps 1 to 6 using the averaged/fixed valve resistances (i.e., without identifying 𝑅mt , 𝑅av , 𝑅tc and 𝑅pv )
and (A42) and (A43).
Step 9: Identify six-chamber model.
Substep 9.1: Simulate six-chamber model.
Substep 9.2: Identify 𝐸vc and 𝐸pu with (A44) and (A45).
Substep 9.3: Resimulate six-chamber model with new parameters.
Substep 9.4: If 𝑃vc has converged within a tolerance of 0.5% go to Step 10; otherwise go back to Substep 9.2.
Step 10: Output six-chamber parameters and model outputs
,
Figure 9: Step-by-step overview of the parameter identification used to create subject-specific CVS models.
Once the systemic and pulmonary models have been identi-
fied with the averaged valve resistances, the final parameters
of the six-chambermodel,𝐸vc and𝐸pu, can be identified.This
is done by using the parameters of systemic and pulmonary
to simulate the six-chamber CVS model. The six-chamber
model is iteratively simulated, and (A.36) and (A.37) are used
to identify 𝐸vc and 𝐸pu. The parameter identification process
is concluded when the mean of the six-chamber 𝑃vc,6 and
𝑃pu,6 matches their corresponding identified values from the
simplified submodels (𝑃vc,simple, 𝑃pu,simple), producing a full
six-chamber subject-specific model of the CVS as follows:
𝐸vc,new = (
𝑃vc,simple
mean (𝑃vc,6)
)𝐸vc,old, (A.36)
𝐸pu,new =
𝑃pu,simple
mean (𝑉pu)
. (A.37)
Figure 9 outlines the steps used to identify the parameters of
the six-chamber CVS model.
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